RadNet, Inc. (RDNT)
- Previous Close
52.21 - Open
52.98 - Bid 52.58 x 600
- Ask 54.38 x 600
- Day's Range
52.83 - 54.39 - 52 Week Range
45.00 - 93.65 - Volume
844,772 - Avg. Volume
875,685 - Market Cap (intraday)
4.004B - Beta (5Y Monthly) 1.59
- PE Ratio (TTM)
1,334.50 - EPS (TTM)
0.04 - Earnings Date May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
71.67
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
www.radnet.com8,546
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: RDNT
View MorePerformance Overview: RDNT
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RDNT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RDNT
View MoreValuation Measures
Market Cap
4.00B
Enterprise Value
4.99B
Trailing P/E
1.33k
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.18
Price/Book (mrq)
4.44
Enterprise Value/Revenue
2.73
Enterprise Value/EBITDA
15.45
Financial Highlights
Profitability and Income Statement
Profit Margin
0.15%
Return on Assets (ttm)
2.35%
Return on Equity (ttm)
3.99%
Revenue (ttm)
1.83B
Net Income Avi to Common (ttm)
2.79M
Diluted EPS (ttm)
0.04
Balance Sheet and Cash Flow
Total Cash (mrq)
740.02M
Total Debt/Equity (mrq)
152.54%
Levered Free Cash Flow (ttm)
51.06M